v3 Template
I

Innovac Therapeutics

Biotechnology ~150 employees
Founded
--
Employees (Est.)
~150
10 leaders known
Total Funding
$18.0M
Funding Rounds
1
Last Funding
2023-09-01

About Innovac Therapeutics

Innovac Therapeutics is a biotechnology company focused on developing innovative vaccines for patients with unmet medical needs, leveraging proprietary RNA technology platforms and manufacturing capabilities.

Products & Services

Innovative mRNA Vaccines:Vaccines developed using proprietary RNA technology to address unmet medical needs.

Specialties

RNA Technology Vaccine Development

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series Pre-A
T: -
FT: Series Pre-A
A: 18000000
MR: -
FA: $18 million
FAN: 18000000
D: 2023-09-01
FD: 2023-09-01
5 investors
Series Pre-A Latest
2023-09-01
$18.0M
5 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

M

Michael (Chi) Zhang

Founder, Chief Executive Officer

N

Nicholas Valiante

Founder, Chief Scientific Officer, President

H

Hang Yuan

Founder, Chief Technical Officer

B

Ben Breton

Head of Computational Biology

H

Hao Li

Senior Scientist, Lipid Chemistry

M

Monia Draghi

VP, Immunology

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Innovac Therapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~150 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro